IMQ-treated Padi4 KO (Padi4 KO-IMQ) mice showed a significant reduction in splenomegaly compared with IMQ-treated WT (WT-IMQ) mice (Figure 1A). This evidence concerns the gene PADI4 and Splenomegaly.